{"id":"W2947312373","doi":"10.1093/annonc/mdz247.158","title":"Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomized, phase III study in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Gemcitabine; Open label; Cisplatin; Oncology; Internal medicine; Randomized controlled trial; Chromosomal translocation; Surgery; Chemotherapy; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001382996,0.002299512,0.004708008,0.0003184461,0.000473932,0.001726624,0.001010931,0.001468104,0.004700565],"category_scores_gemma":[0.001483056,0.0008560887,0.002815786,0.0004970069,0.001379784,0.002159614,0.0006275654,0.004722249,0.001227774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001244101,"about_ca_system_score_gemma":0.001397621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001109984,"about_ca_topic_score_gemma":0.003382222,"domain_scores_codex":[0.9995564,0.0002007784,0.00002702071,0.00009438866,0.00003122618,0.00009018026],"domain_scores_gemma":[0.9993706,0.0001144374,0.000151252,0.00006230356,0.00004151282,0.0002599004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9466663,0.004634088,0.001625266,0.001074879,0.002238856,0.0001111018,0.0001265376,0.001547339,0.003910694,0.0003911159,0.002768172,0.03490574],"study_design_scores_gemma":[0.9434175,0.05086,0.002295269,0.0000368372,0.0007088979,0.0001098945,0.0000571058,0.0005591816,0.0003400446,0.0003867819,0.001198948,0.00002959749],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839494,0.00766723,0.0007414072,0.001681188,0.0007890841,0.001781155,0.001331451,0.0001401132,0.001919035],"genre_scores_gemma":[0.983375,0.004615279,0.001844071,0.001774506,0.0003471493,0.001945262,0.002205554,0.0000594532,0.003833641],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004708008,"threshold_uncertainty_score":0.01572496,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06011972269563243,"score_gpt":0.3937258460936424,"score_spread":0.33360612339801,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}